Cargando…

Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond

Fungal infections are underestimated threats that affect over 1 billion people, and Candida spp., Cryptococcus spp., and Aspergillus spp. are the 3 most fatal fungi. The treatment of these infections is performed with a limited arsenal of antifungal drugs, and the class of the azoles is the most use...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastos, Rafael W., Rossato, Luana, Goldman, Gustavo H., Santos, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659312/
https://www.ncbi.nlm.nih.gov/pubmed/34882756
http://dx.doi.org/10.1371/journal.ppat.1010073
_version_ 1784612934946652160
author Bastos, Rafael W.
Rossato, Luana
Goldman, Gustavo H.
Santos, Daniel A.
author_facet Bastos, Rafael W.
Rossato, Luana
Goldman, Gustavo H.
Santos, Daniel A.
author_sort Bastos, Rafael W.
collection PubMed
description Fungal infections are underestimated threats that affect over 1 billion people, and Candida spp., Cryptococcus spp., and Aspergillus spp. are the 3 most fatal fungi. The treatment of these infections is performed with a limited arsenal of antifungal drugs, and the class of the azoles is the most used. Although these drugs present low toxicity for the host, there is an emergence of therapeutic failure due to azole resistance. Drug resistance normally develops in patients undergoing azole long-term therapy, when the fungus in contact with the drug can adapt and survive. Conversely, several reports have been showing that resistant isolates are also recovered from patients with no prior history of azole therapy, suggesting that other routes might be driving antifungal resistance. Intriguingly, antifungal resistance also happens in the environment since resistant strains have been isolated from plant materials, soil, decomposing matter, and compost, where important human fungal pathogens live. As the resistant fungi can be isolated from the environment, in places where agrochemicals are extensively used in agriculture and wood industry, the hypothesis that fungicides could be driving and selecting resistance mechanism in nature, before the contact of the fungus with the host, has gained more attention. The effects of fungicide exposure on fungal resistance have been extensively studied in Aspergillus fumigatus and less investigated in other human fungal pathogens. Here, we discuss not only classic and recent studies showing that environmental azole exposure selects cross-resistance to medical azoles in A. fumigatus, but also how this phenomenon affects Candida and Cryptococcus, other 2 important human fungal pathogens found in the environment. We also examine data showing that fungicide exposure can select relevant changes in the morphophysiology and virulence of those pathogens, suggesting that its effect goes beyond the cross-resistance.
format Online
Article
Text
id pubmed-8659312
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-86593122021-12-10 Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond Bastos, Rafael W. Rossato, Luana Goldman, Gustavo H. Santos, Daniel A. PLoS Pathog Review Fungal infections are underestimated threats that affect over 1 billion people, and Candida spp., Cryptococcus spp., and Aspergillus spp. are the 3 most fatal fungi. The treatment of these infections is performed with a limited arsenal of antifungal drugs, and the class of the azoles is the most used. Although these drugs present low toxicity for the host, there is an emergence of therapeutic failure due to azole resistance. Drug resistance normally develops in patients undergoing azole long-term therapy, when the fungus in contact with the drug can adapt and survive. Conversely, several reports have been showing that resistant isolates are also recovered from patients with no prior history of azole therapy, suggesting that other routes might be driving antifungal resistance. Intriguingly, antifungal resistance also happens in the environment since resistant strains have been isolated from plant materials, soil, decomposing matter, and compost, where important human fungal pathogens live. As the resistant fungi can be isolated from the environment, in places where agrochemicals are extensively used in agriculture and wood industry, the hypothesis that fungicides could be driving and selecting resistance mechanism in nature, before the contact of the fungus with the host, has gained more attention. The effects of fungicide exposure on fungal resistance have been extensively studied in Aspergillus fumigatus and less investigated in other human fungal pathogens. Here, we discuss not only classic and recent studies showing that environmental azole exposure selects cross-resistance to medical azoles in A. fumigatus, but also how this phenomenon affects Candida and Cryptococcus, other 2 important human fungal pathogens found in the environment. We also examine data showing that fungicide exposure can select relevant changes in the morphophysiology and virulence of those pathogens, suggesting that its effect goes beyond the cross-resistance. Public Library of Science 2021-12-09 /pmc/articles/PMC8659312/ /pubmed/34882756 http://dx.doi.org/10.1371/journal.ppat.1010073 Text en © 2021 Bastos et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Bastos, Rafael W.
Rossato, Luana
Goldman, Gustavo H.
Santos, Daniel A.
Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond
title Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond
title_full Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond
title_fullStr Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond
title_full_unstemmed Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond
title_short Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond
title_sort fungicide effects on human fungal pathogens: cross-resistance to medical drugs and beyond
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659312/
https://www.ncbi.nlm.nih.gov/pubmed/34882756
http://dx.doi.org/10.1371/journal.ppat.1010073
work_keys_str_mv AT bastosrafaelw fungicideeffectsonhumanfungalpathogenscrossresistancetomedicaldrugsandbeyond
AT rossatoluana fungicideeffectsonhumanfungalpathogenscrossresistancetomedicaldrugsandbeyond
AT goldmangustavoh fungicideeffectsonhumanfungalpathogenscrossresistancetomedicaldrugsandbeyond
AT santosdaniela fungicideeffectsonhumanfungalpathogenscrossresistancetomedicaldrugsandbeyond